Oakmont Advisory Group’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Sell
7,583
-248
-3% -$12.1K 0.35% 68
2026
Q1
$336K Buy
7,831
+506
+7% +$21.8K 0.34% 78
2025
Q4
$321K Buy
+7,325
New +$303K 0.34% 93

Other funds holding EXEL

Oakmont Advisory Group's EXEL Position: Q2 2026 in Review

Oakmont Advisory Group reduced its Exelixis (EXEL) stake by 3.2% in Q2 2026, selling an estimated $12.1K and leaving 7,583 shares worth $413K. The position accounts for 0.35% of the portfolio, ranked #68.

Oakmont Advisory Group first reported a position in EXEL in Q4 2025 and has held it in 3 quarters since. 753 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Oakmont Advisory Group held 7,583 shares of Exelixis worth $413K as of Q2 2026.
  • Oakmont Advisory Group sold 248 Exelixis shares in Q2 2026, an estimated $12.1K.
  • Exelixis made up 0.35% of Oakmont Advisory Group's portfolio in Q2 2026, its #68 holding.
  • Oakmont Advisory Group first reported a position in Exelixis in Q4 2025 and has held it in 3 quarters since.
  • 753 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.